How selective antagonists and genetic modification have helped characterise the expression and functions of vascular P2Y receptors
Open Access
- 13 May 2024
- journal article
- research article
- Published by Springer Nature in Purinergic Signalling
- Vol. 21 (1) , 11-22
Abstract
Vascular P2Y receptors mediate many effects, but the role of individual subtypes is often unclear. Here we discuss how subtype-selective antagonists and receptor knockout/knockdown have helped identify these roles in numerous species and vessels. P2Y1 receptor-mediated vasoconstriction and endothelium-dependent vasodilation have been characterised using the selective antagonists, MRS2179 and MRS2216, whilst AR-C118925XX, a P2Y2 receptor antagonist, reduced endothelium-dependent relaxation, and signalling evoked by UTP or fluid shear stress. P2Y2 receptor knockdown reduced endothelial signalling and endothelial P2Y2 receptor knockout produced hypertensive mice and abolished vasodilation elicited by an increase in flow. UTP-evoked vasoconstriction was also blocked by AR-C118925XX, but the effects of P2Y2 receptor knockout were complex. No P2Y4 receptor antagonists are available and P2Y4 knockout did not affect the vascular actions of UTP and UDP. The P2Y6 receptor antagonist, MRS2578, identified endothelial P2Y6 receptors mediating vasodilation, but receptor knockout had complex effects. MRS2578 also inhibited, and P2Y6 knockout abolished, contractions evoked by UDP. P2Y6 receptors contribute to the myogenic tone induced by a stepped increase in vascular perfusion pressure and possibly to the development of atherosclerosis. The P2Y11 receptor antagonists, NF157 and NF340, inhibited ATP-evoked signalling in human endothelial cells. Vasoconstriction mediated by P2Y12/P2Y13 and P2Y14 receptors was characterised using the antagonists, cangrelor, ticagrelor, AR-C67085 and MRS2211 or PPTN respectively. This has yet to be backed up by receptor knockout experiments. Thus, subtype-selective antagonists and receptor knockout/knockdown have helped identify which P2Y subtypes are functionally expressed in vascular smooth muscle and endothelial cells and the effects that they mediate.Keywords
This publication has 92 references indexed in Scilit:
- Nucleotide coronary vasodilation in guinea pig heartsAmerican Journal of Physiology-Heart and Circulatory Physiology, 2003
- The G protein-coupled receptor repertoires of human and mouseProceedings of the National Academy of Sciences, 2003
- Extracellular nucleotides induce vasodilatation in human arteries via prostaglandins, nitric oxide and endothelium‐derived hyperpolarising factorBritish Journal of Pharmacology, 2003
- Regional variation in P2 receptor expression in the rat pulmonary arterial circulationBritish Journal of Pharmacology, 2002
- P2Y1 and P2Y2 receptors are coupled to the NO/cGMP pathway to vasodilate the rat arterial mesenteric bedBritish Journal of Pharmacology, 2002
- Nucleotide‐mediated relaxation in guinea‐pig aorta: selective inhibition by MRS2179British Journal of Pharmacology, 2002
- Identification and biological activity of the active metabolite of clopidogrel.2000
- Agonist Action of Adenosine Triphosphates at the Human P2Y1 ReceptorMolecular Pharmacology, 1998
- Identification of an Ecto-nucleoside Diphosphokinase and Its Contribution to Interconversion of P2 Receptor AgonistsJournal of Biological Chemistry, 1997
- A dual function for adenosine 5'-triphosphate in the regulation of vascular tone. Excitatory cotransmitter with noradrenaline from perivascular nerves and locally released inhibitory intravascular agent.Circulation Research, 1986